Business Standard

Sunday, December 22, 2024 | 11:32 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Drugmaker Sanofi to raise over $11 billion via sale of Regeneron shares

Earlier this week, Regeneron had said it would repurchase about $5 billion of its shares directly from Sanofi, without altering their over-a-decade-long partnership

Logo of French drugmaker Sanofi | Photo: Reuters
Premium

Sanofi will continue to own approximately 400,000 shares of Regeneron's common stock

Agencies
Sanofi will raise over $11 billion from the sale of 21.6 million shares in its US partner Regeneron, the French drugmaker said on Wednesday, adding it would use the proceeds for innovation and general growth.

Earlier this week, Regeneron had said it would repurchase about $5 billion of its shares directly from Sanofi, without altering their over-a-decade-long partnership.

Sanofi is selling the Regeneron shares at $515.00 per share - a discount of around 5.5 per cent to Regeneron's closing price of $545.21 on May 26, and raising gross proceeds of $11.1 billion, the Reuters reported.

ALSO READ: 
Topics : Sanofi

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in